188 related articles for article (PubMed ID: 15631037)
1. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma.
van der Kolk JH; Heinrichs M; van Amerongen JD; Stooker RC; in de Wal LJ; van den Ingh TS
Am J Vet Res; 2004 Dec; 65(12):1701-7. PubMed ID: 15631037
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.
Okada T; Shimomuro T; Oikawa M; Nambo Y; Kiso Y; Morikawa Y; Liptrap RM; Yamashiro S; Little PB; Sasaki F
Am J Vet Res; 1997 Aug; 58(8):920-4. PubMed ID: 9256982
[TBL] [Abstract][Full Text] [Related]
3. Age-related Qualitative Histological and Quantitative Stereological Changes in the Equine Pituitary.
Leitenbacher J; Herbach N
J Comp Pathol; 2016; 154(2-3):215-24. PubMed ID: 26810844
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of equine pituitary pars intermedia adenoma.
van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
Domest Anim Endocrinol; 1995 Jan; 12(1):35-9. PubMed ID: 7621678
[TBL] [Abstract][Full Text] [Related]
5. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).
van der Kolk JH; Kalsbeek HC; van Garderen E; Wensing T; Breukink HJ
Vet Rec; 1993 Dec; 133(24):594-7. PubMed ID: 8116170
[TBL] [Abstract][Full Text] [Related]
6. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse.
Horvath CJ; Ames TR; Metz AL; Larson VL
J Am Vet Med Assoc; 1988 Feb; 192(3):367-71. PubMed ID: 2833479
[TBL] [Abstract][Full Text] [Related]
7. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
8. Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses.
Loeb WF; Capen CC; Johnson LE
Cornell Vet; 1966 Oct; 56(4):623-39. PubMed ID: 6008349
[No Abstract] [Full Text] [Related]
9. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
10. Functional morphology of spontaneous hyperplastic and neoplastic lesions in the canine pituitary gland.
El Etreby MF; Müller-Peddinghaus R; Bhargava AS; Trautwein G
Vet Pathol; 1980 Mar; 17(2):109-22. PubMed ID: 6244687
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses.
Heinrichs M; Baumgärtner W; Capen CC
Vet Pathol; 1990 Nov; 27(6):419-25. PubMed ID: 2177580
[TBL] [Abstract][Full Text] [Related]
12. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
[TBL] [Abstract][Full Text] [Related]
13. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunohistochemical study of stellate cells in normal canine and equine adenohypophyses and in pituitary tumours.
Méndez A; Martín de las Mulas J; Bautista MJ; Chacón F; Millán Y; Fondevila D; Pumarola M
J Comp Pathol; 1998 Jan; 118(1):29-40. PubMed ID: 9500236
[TBL] [Abstract][Full Text] [Related]
15. [Interstitial cell adenoma of the hypophysis with Cushing-like symptomatology in the horse].
Pauli BU; Rossi Straub R
Vet Pathol; 1974; 11(5):417-29. PubMed ID: 4376879
[No Abstract] [Full Text] [Related]
16. The oral glucose test predicts laminitis risk in ponies fed a diet high in nonstructural carbohydrates.
Meier AD; de Laat MA; Reiche DB; Pollitt CC; Walsh DM; McGree JM; Sillence MN
Domest Anim Endocrinol; 2018 Apr; 63():1-9. PubMed ID: 29172109
[TBL] [Abstract][Full Text] [Related]
17. Agreement in histologic assessments of the pituitary pars intermedia in aged horses.
McFarlane D; Miller LM; Craig LE; Dybdal NO; Habecker PL; Miller MA; Patterson JS; Cribb AE
Am J Vet Res; 2005 Dec; 66(12):2055-9. PubMed ID: 16379646
[TBL] [Abstract][Full Text] [Related]
18. Pituitary pars intermedia dysfunction with pituitary gland melanotroph adenoma in a Grevy's zebra (Equus grevyi).
Takahashi N; Chambers JK; Ota K; Toda K; Yoshimoto Y; Miyajima U; Uchida K
J Vet Med Sci; 2024 Jan; 86(1):71-76. PubMed ID: 37981318
[TBL] [Abstract][Full Text] [Related]
19. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction.
Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE
Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438
[TBL] [Abstract][Full Text] [Related]
20. Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma.
Beech J; Garcia M
Am J Vet Res; 1985 Sep; 46(9):1941-3. PubMed ID: 3931519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
